学会発表
Innovation of the first-line strategy optimized as abemaciclib with endocrine therapy based on the ESR1 mutation of ctDNA for patients with HR-positive HER2-negative advanced metastatic breast cancer (JBCRG-M08; AMBER study).
Tetsuhiro Yoshinami, Shinsuke Sasada, Meiko Nishimura, Madoka Iwase, Chiya Oshiro, Kaori Terata, Mikiya Ishihara, Hiroko Bando, Masahiko Tanabe, Nobuyasu Yoshimoto, Sayuri Akiyoshi, Masahiro Takada, Hiroshi Ishiguro, Shigehira Saji, Satoshi Morita, Norikazu Masuda
ASCO, 2024 June, Chicago, USA（Poster）
Identification of Prognostic and Predictive Biomarkers for Palbociclib Add-On Therapy using Cancer Panel Sequencing of Cell-Free DNA in Patients with HR-Positive/HER2-Negative Advanced and Metastatic Breast Cancer with Fulvestrant Resistance
Takashi Takeshita, Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji
AACR, 2024 Apr, San Diego, USA（Poster）
Pertuzumab retreatment in patients with HER2-positive locally advanced/metastatic breast cancer: overall survival results of a phase III randomized trial (JBCRG-M05: PRECIOUS)
Masato Takahashi, Yutaka Yamamoto, Hiroji Iwata, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, Masahiro Kashiwaba, Koichiro Tsugawa, Yoshie Hasegawa, Kenji Tamura, Hiroshi Tada, Fumikata Hara, Naruto Taira, Shigehira Saji, Satoshi Morita, Masakazu Toi, Shinji Ohno, Norikazu Masuda on behalf of the PRECIOUS Study Group
第21回日本臨床腫瘍学会学術集会, 2024 Feb, Nagoya, Japan（Oral）
Second interim Analysis of REIWA study(JBCRG-C07), Observational study of gene panel testing in metastatic breast cancer
Hiroshi Tada, Hiroko Masuda, Yayoi Adachi, Tsuguo Iwatani, Yasuaki Uemoto, Yoko Otani, Yukiko Kajiwara, Dai Kitagawa, Takahiro Kogawa, Yasuaki Sagara, Tadahiko Shien, Yuko Tanabe, Maki Tanioka, Fumikata Hara, Hiroyuki Yasojima, Masaya Hattori, Kenichi Yoshimura, Hiroji Iwata, Norikazu Masuda
第21回日本臨床腫瘍学会学術集会, 2024 Feb, Nagoya, Japan（Oral）
Health-Related QOL and Physical Activity Collected via Wearable Device in Patients With HR+/HER2–Advanced Breast Cancer in Japan. Treated With Palbociclib+Endocrine Therapy (ET) or ET Alone: 6-Month Longitudinal Study (JBCRG-26)
Hiroko Bando, Mari Oba, Aya Ueda, Kaori Terata, Mihoko Doi, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Manabu Futamura, Kei Koizumi, Naoki Niikura, Tempei Miyaji, Yasuaki Muramatsu, Linghua Xu, Norikazu Masuda, Shigehira Saji
San Antonio Breast Cancer Symposium, 2023 Dec, Texas USA (Poster)
Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
Hatem A Azim J, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B. Saetersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E Lee, Janice M. Walshe, Manuel Ruíz-Borrego, Halle C F Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, N. J. Klar, Tanja. Spanic, Kathryn Ruddy, Martine Piccart, Larissa A Korde, Aron Goldhirsch †, Richard D Gelber, Olivia Pagani, Fedro A Peccatori
San Antonio Breast Cancer Symposium, 2023 Dec, Texas USA (Oral)
HR陽性HER2陰性進行転移乳癌のアベマシクリブによる一次治療中のESR1変異に基づく治療戦略の検討：JBCRG M08（AMBER試験）
大城智弥、吉波哲大、笹田伸介、岩瀬まどか、坂東裕子、石原幹也、寺田かおり、吉本信保、田辺真彦、髙田正泰、秋吉清百合、森田智視、増田慎三
第21回日本乳癌学会近畿地方会, 2023 Nov, Osaka, Japan（一般演題）
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer
Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji
ESMO, 2023 Oct, Madrid Spain (ポスター)
原発性HER2陽性乳癌に対するT-DM1術前薬物療法の可能性(JBCRG-20)
増田慎三, 伊藤充矢, 田辺裕子, 井上賢一, 河口浩介, 八十島宏行, 高野利実, 坂東裕子, 中村力也, 山中隆司, 石田和茂, 有賀智之, 柳田康弘, 徳永えり子, 青儀健二郎, 大野真司, 笠井宏委, 片岡竜貴, 森田智視, 戸井雅和
第31回日本乳癌学会学術総会, 2023 Jul, Yokohama (ポスター)
ER陽性/HER陰性進行再発乳癌に対する酢酸メドロキシプロゲステロンの有効性に関する検討
冨口麻衣, 川口英俊, 山本豊, 佐治重衡, 増田慎三, 中山貴寛, 青儀健二郎, 阿南敬生, 大谷彰一郎, 金子耕司, 徳永えり子, 中村清吾, 長谷川善枝, 服部正也, 藤澤知巳, 森田智視, 山口美樹, 山下年成, 戸井雅和, 大野真司
第31回日本乳癌学会学術総会, 2023 Jul, Yokohama (ポスター)